论文部分内容阅读
目的探究炎症性乳腺癌的临床病理特征以及生物学行为。方法回顾性分析48例炎症性乳腺癌患者的超声资料以及病理资料。结果 48例患者的病理分型分别为黏液癌、浸润性小叶癌以及浸润性导管癌;所有患者的病理资料均显示存在真皮下淋巴管内癌栓,所有炎症性乳腺癌患者的雌激素受体(ER)、孕激素受体(PR)、癌基因CerbB-2三类免疫表型的阳性率分别为31.2%、43.7%和62.5%。结论炎症性乳腺癌的病理学特征与其生物学行为存在一定的相关性,且其病理特征与临床行为表现均具有明显的特点,可通过对患者生物学行为及预后的评估,采用综合治疗方案达到更佳的效果。
Objective To investigate the clinicopathological features and biological behavior of inflammatory breast cancer. Methods A retrospective analysis of 48 cases of inflammatory breast cancer patients with ultrasound data and pathological data. Results The pathological types of 48 patients were mucinous carcinoma, invasive lobular carcinoma and invasive ductal carcinoma. Pathological data of all patients showed subcutaneous subcutaneous lymphatic tumor thrombus, and all inflammatory breast cancer patients had estrogen receptor The positive rates of ER, PR and CerbB-2 were 31.2%, 43.7% and 62.5% respectively. Conclusion The pathological features of inflammatory breast cancer have some correlation with their biological behavior, and their pathological features and clinical behaviors have obvious characteristics. Through the evaluation of the biological behavior and prognosis of patients, the comprehensive treatment plan is adopted Better effect.